HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Xia Selected Research

phosphohistidine

10/2021LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway.
1/2020Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Xia Research Topics

Disease

41Neoplasms (Cancer)
06/2022 - 12/2009
13Hepatocellular Carcinoma (Hepatoma)
06/2022 - 03/2011
10Breast Neoplasms (Breast Cancer)
04/2021 - 03/2002
9Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2015
8Neoplasm Metastasis (Metastasis)
01/2022 - 03/2011
8COVID-19
12/2021 - 01/2020
5Ischemia
06/2022 - 03/2016
5Inflammation (Inflammations)
03/2022 - 10/2016
5Carcinogenesis
10/2021 - 12/2009
5Osteoarthritis
10/2021 - 07/2014
4Acute Kidney Injury (Acute Renal Failure)
06/2022 - 01/2020
4Fibrosis (Cirrhosis)
04/2022 - 12/2014
4Infections
03/2022 - 06/2013
4Pain (Aches)
01/2022 - 01/2012
4Alzheimer Disease (Alzheimer's Disease)
01/2020 - 08/2010
4Spinal Cord Injuries (Spinal Cord Injury)
01/2020 - 02/2016
3Stroke (Strokes)
02/2022 - 01/2020
3Ureteral Obstruction
01/2022 - 12/2014
3Chromosomal Instability (Chromosome Stability)
12/2021 - 05/2013
3Critical Illness (Critically Ill)
12/2021 - 01/2020
3Proteinuria
11/2021 - 05/2011
3Heart Failure
06/2021 - 01/2016
3Necrosis
01/2021 - 10/2019
3Myocardial Infarction
01/2021 - 01/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2013
3Cardiotoxicity
01/2020 - 01/2016
3Pulmonary Arterial Hypertension
01/2019 - 05/2017
3Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 07/2015
3Stomach Neoplasms (Stomach Cancer)
01/2017 - 02/2014
3Arteriosclerosis
01/2017 - 06/2012
3Reperfusion Injury
11/2016 - 01/2016
2Thrombosis (Thrombus)
05/2022 - 06/2021
2Carcinoma (Carcinomatosis)
04/2022 - 01/2019
2Paralysis (Palsy)
02/2022 - 12/2021
2Prostatic Neoplasms (Prostate Cancer)
04/2021 - 06/2015
2Disease Progression
01/2021 - 01/2019
2Sepsis (Septicemia)
01/2021 - 11/2020
2Cardiomyopathies (Cardiomyopathy)
01/2021 - 12/2018
2Cognitive Dysfunction
11/2020 - 01/2020
2Cytokine Release Syndrome
11/2020 - 01/2020
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 01/2019
2Septic Shock (Toxic Shock Syndrome)
01/2020 - 12/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2020
2Pathologic Constriction (Stenosis)
01/2019 - 01/2016
2Liver Neoplasms (Liver Cancer)
01/2019 - 06/2014
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2018 - 01/2015
2Cardiovascular Diseases (Cardiovascular Disease)
03/2018 - 01/2016
2Type 2 Diabetes Mellitus (MODY)
01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2009
17Biomarkers (Surrogate Marker)IBA
06/2022 - 12/2009
8Pharmaceutical PreparationsIBA
05/2020 - 03/2002
7Long Noncoding RNAIBA
01/2022 - 12/2017
6Messenger RNA (mRNA)IBA
01/2022 - 05/2014
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2013
6MicroRNAs (MicroRNA)IBA
01/2021 - 11/2016
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2015
4RNA (Ribonucleic Acid)IBA
03/2022 - 02/2019
4Sirolimus (Rapamycin)FDA Link
01/2022 - 05/2011
4EnzymesIBA
01/2022 - 05/2014
4Circular RNAIBA
01/2020 - 01/2017
4Small Interfering RNA (siRNA)IBA
10/2019 - 12/2009
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021 - 09/2015
3Immunoglobulin G (IgG)IBA
06/2021 - 01/2016
3CytokinesIBA
01/2021 - 07/2010
3AntioxidantsIBA
01/2021 - 12/2017
3Antiphospholipid AntibodiesIBA
12/2020 - 01/2020
3ezrinIBA
01/2020 - 12/2009
3Glucose (Dextrose)FDA LinkGeneric
10/2019 - 01/2017
3Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2019 - 01/2017
3Therapeutic UsesIBA
08/2018 - 05/2016
3salicylhydroxamic acid (SHAM)IBA
01/2018 - 03/2016
3IntegrinsIBA
11/2015 - 07/2014
3Mitochondrial DNA (mtDNA)IBA
01/2014 - 08/2009
2Indicators and Reagents (Reagents)IBA
05/2022 - 06/2021
2Activins (Activin)IBA
05/2022 - 06/2021
2ADAMTS13 ProteinIBA
05/2022 - 06/2021
2ResveratrolIBA
04/2022 - 12/2014
2Hemoglobins (Hemoglobin)IBA
04/2022 - 01/2020
2InterferonsIBA
03/2022 - 01/2020
2Sorafenib (BAY 43-9006)FDA Link
01/2022 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021 - 01/2020
2diphosphoric acid (pyrophosphoric acid)IBA
10/2021 - 01/2020
2phosphohistidineIBA
10/2021 - 01/2020
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2021 - 01/2020
2Antisense RNA (Anti-Sense RNA)IBA
01/2021 - 01/2020
2AntibodiesIBA
12/2020 - 05/2016
2Immunoglobulin A (IgA)IBA
12/2020 - 07/2010
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2020
2AnthracyclinesIBA
01/2020 - 12/2018
2Insulin (Novolin)FDA Link
10/2019 - 12/2017
2MonocrotalineIBA
01/2019 - 05/2017
2Biological ProductsIBA
01/2019 - 05/2014
2Receptor for Advanced Glycation End ProductsIBA
08/2018 - 01/2018
2SodiumIBA
01/2018 - 01/2017
2SymportersIBA
01/2018 - 01/2017

Therapy/Procedure

15Therapeutics
06/2021 - 06/2012
6Drug Therapy (Chemotherapy)
06/2021 - 05/2014
2Renal Dialysis (Hemodialysis)
12/2022 - 01/2020
2Nerve Transfer
02/2022 - 12/2021